WCN25-3663 EFFECTIVENESS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VERSUS ANGIOTENSIN RECEPTOR BLOCKERS OR THEIR COMBINATION ON MORTALITY IN MAINTENANCE DIALYSIS PATIENTS: A META-ANALYSIS OF 126,612 PATIENTS

WCN25-3663 EFFECTIVENESS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VERSUS ANGIOTENSIN RECEPTOR BLOCKERS OR THEIR COMBINATION ON MORTALITY IN MAINTENANCE DIALYSIS PATIENTS: A META-ANALYSIS OF 126,612 PATIENTS

Saved in:

Bibliographic Details
Main Authors:	Omar Elkoumi, Ahmed Elkoumi, Mariam Khaled Elbairy, Ahmad Beddor, Mostafa Adel T. Mahmoud, Omar K. Habib, Nada Ibrahim Hendi, Sarah Hamed, Ayah Abdulgadir, Bandar Alawlaqi, Ahmed Khaled
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924028067
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-3980 IMPACT OF DEXMEDETOMIDINE ON REDUCING ACUTE KIDNEY INJURY RISK FOLLOWING CORONARY ARTERY BYPASS GRAFTING: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: Omar Elkoumi, et al.
Published: (2025-02-01)

WCN25-3711 EFFICACY AND SAFETY OUTCOMES OF ANTI-TUBERCULAR TREATMENT IN CHRONIC KIDNEY PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: Omar Elkoumi, et al.
Published: (2025-02-01)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Myla E. Moretti, et al.
Published: (2012-01-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
by: Hye-Ran Jun, et al.
Published: (2021-01-01)

Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
by: James A. Ker
Published: (2015-05-01)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
by: Marco Rossato, et al.
Published: (2020-07-01)

SYSTOLIC ARTERIAL HYPERTENSION: THE PLACE OF ANGIOTENSIN II RECEPTOR BLOCKERS
by: D. V. Nebieridze
Published: (2002-02-01)

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
by: G. Savarese, et al.
Published: (2015-09-01)

Effect of insertion/deletion polymorphism of angiotensin-converting enzyme gene on efficacy of antihypertensive therapy with angiotensin II receptor blockers
by: E. V. Rebrova, et al.
Published: (2024-01-01)

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.
by: Mingfei Li, et al.
Published: (2021-01-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY
by: S. Yu. Martsevich
Published: (2015-09-01)

Impact of Different Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker Resumption Timing on Post Acute Kidney Injury Outcomes
by: Jia-Jin Chen, et al.
Published: (2024-11-01)

Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients With Hypertension Combined Prediabetes
by: Chenyu Yang, et al.
Published: (2025-05-01)

Angiotensin receptor blockers: rational prescription tailored to the cardiovascular risk and comorbidities
by: V. I. Podzolkov, et al.
Published: (2018-12-01)

Renal Outcomes With Renin-Angiotensin System Blockers After Unilateral Nephrectomy
by: Sehun Lee, et al.
Published: (2025-01-01)

Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients
by: Ali Kaan Güren, et al.
Published: (2025-04-01)

Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With a Reduced Risk of Poststroke Epilepsy in Patients With Ischemic Stroke
by: Kuo‐Cheng Chang, et al.
Published: (2024-09-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study
by: Seok Hui Kang, et al.
Published: (2024-12-01)

Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in Older Patients with acute Myocardial Infarction after a Successful Stent Implantation
by: Geum Ko, et al.
Published: (2025-06-01)

Clinical pharmacogenetics of angiotensin II receptor blockers: new perspectives of pharmacotherapy individualization
by: D. A. Sychev, et al.
Published: (2006-04-01)

Comparing recommended doses of angiotensin receptor blockers and ACE inhibitors (CORD Study)
by: J. Spinar, et al.
Published: (2009-08-01)

Use of angiotensin receptor blockers in cardiovascular protection. Current evidence and future directions
by: M. A. Munger
Published: (1970-01-01)

POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK
by: Z M. Sizova
Published: (2015-09-01)

INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS
by: V. V. Fomin
Published: (2016-01-01)

RU28318, an Aldosterone Antagonist, in Combination with an ACE Inhibitor and Angiotensin Receptor Blocker Attenuates Cardiac Dysfunction in Diabetes
by: Ibrahim F. Benter, et al.
Published: (2013-01-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT
by: S. Yu. Martsevich
Published: (2015-09-01)

The impact of different angiotensin II receptor blockers on the stiffness of the large arteries and effectiveness of therapy
by: O. L. Rekovets, et al.
Published: (2022-12-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2012-09-01)

Non‐genetic factors associated with ACE‐inhibitor and angiotensin receptor blocker‐induced angioedema
by: Diana Dubrall, et al.
Published: (2025-05-01)

Efficacy of angiotensin receptor blockers for erectile dysfunction in hypertensive men: A systematic review
by: Swati Sucharita Dash, et al.
Published: (2024-01-01)

Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
by: Ivona Yanovna Yarek-Martynova, et al.
Published: (2010-06-01)

The association between the use of angiotensin-converting enzyme inhibitors /angiotensin receptor blockers and the development of ventilator-associated pneumonia in the intensive care unit: a retrospective cohort study
by: Hongfeng Cai, et al.
Published: (2024-11-01)

Pharma dynamics launches Zartan 50 mg — the first generic Angiotensin Receptor Blocker (ARB)
by: Editorial Office
Published: (2007-10-01)

Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2007-08-01)

Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers?
by: V. V. Fomin, et al.
Published: (2007-06-01)

Labial adhesions due to vulvovaginal lichen planus suspected to be caused by angiotensin II receptor blocker
by: Yugo Sawada, et al.
Published: (2025-03-01)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
by: Haotian Ma, et al.
Published: (2021-01-01)